Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Urologic Neoplasms × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5 Neoplasms 4 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Lung Neoplasms 2 Infertility 2 Fatigue 2 Depression 2 Carcinoma, Squamous Cell 2 Carcinoma, Hepatocellular 2 Anxiety Disorders 2 Advanced Solid Tumor 2 Urologic Neoplasms 1 Stress, Psychological 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sezary Syndrome 1 Sexual Dysfunction, Physiological 1 Sarcoma, Kaposi 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumoperitoneum 1 Peritoneal Neoplasms 1 Periampullary Tumors 1 Pain 1

Interventions

tislelizumab 1 atezolizumab 1 Water 1 Therapeutics 1 Surgical Procedures, Operative 1 Immunoglobulins, Intravenous 1 Dosage Forms 1 Biological Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡